ProShare Advisors
PRCT icon

ProShare Advisors’s Procept Biorobotics PRCT Stock Holding History

ProShare Advisors’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9,726
Closed -$306K – 1989
2025
Q4 		$306K Buy
9,726
+438
+5% +$14.5K ﹤0.01% 1446
2025
Q3 		$331K Sell
9,288
-1,841
-17% -$84.1K ﹤0.01% 1351
2025
Q2 		$641K Buy
11,129
+1,308
+13% +$74K ﹤0.01% 981
2025
Q1 		$572K Sell
9,821
-2,901
-23% -$198K ﹤0.01% 1021
2024
Q4 		$1.02M Buy
12,722
+4,459
+54% +$381K ﹤0.01% 902
2024
Q3 		$662K Buy
8,263
+2,598
+46% +$185K ﹤0.01% 972
2024
Q2 		$346K Sell
5,665
-1,585
-22% -$94.3K ﹤0.01% 1189
2024
Q1 		$358K Buy
7,250
+570
+9% +$27.1K ﹤0.01% 1302
2023
Q4 		$280K Buy
+6,680
New +$227K ﹤0.01% 1433

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ProShare Advisors's PRCT Position: Q1 2026 in Review

ProShare Advisors sold out of Procept Biorobotics (PRCT) in Q1 2026, closing a stake of 9,726 shares — an estimated $306K sold.

ProShare Advisors first reported a position in PRCT in Q4 2023 and held it in 9 quarters. The position peaked at $1.02M in Q4 2024. 257 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • ProShare Advisors reported no remaining Procept Biorobotics position as of Q1 2026 after selling out during the quarter.
  • ProShare Advisors sold 9,726 Procept Biorobotics shares in Q1 2026, an estimated $306K.
  • ProShare Advisors first reported a position in Procept Biorobotics in Q4 2023 and held it in 9 quarters.
  • ProShare Advisors's Procept Biorobotics position peaked at $1.02M in Q4 2024.
  • 257 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.